Literature DB >> 11093277

Two novel mutations confirm FGD1 is responsible for the Aarskog syndrome.

C E Schwartz1, G Gillessen-Kaesbach, M May, M Cappa, J Gorski, K Steindl, G Neri.   

Abstract

The Aarskog syndrome or facio-genital dysplasia (FGDY, MIM No. 305400) is an X-linked condition characterized by short stature, macrocephaly, facial, genital and skeletal anomalies. It is caused by mutation of the FGD1 gene mapped to the Xp11.21 region. To date, only one point mutation has been reported in an affected family, consisting of the insertion of an additional guanine residue at nucleotide 2122 of exon 7, which causes premature translational termination. We now report the finding of two novel FGD1 mutations, a missense mutation in a family of Italian origin and a deletion of 3 exons in a sporadic case from Germany. These mutations confirm the role of FGD1 as the gene responsible for the Aarskog syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093277     DOI: 10.1038/sj.ejhg.5200553

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  16 in total

1.  Association of FGD1 polymorphisms with early-onset breast cancer.

Authors:  Sarah Beasley; Phillip J Buckhaults; Nancy G Pedigo; Christopher L Farrell
Journal:  Oncol Lett       Date:  2016-07-25       Impact factor: 2.967

2.  Clinical utility gene card for: Aarskog-Scott syndrome (faciogenital dysplasia).

Authors:  Alfredo Orrico; Lucia Galli; Jill Clayton-Smith; Jean-Pierre Fryns
Journal:  Eur J Hum Genet       Date:  2011-06-08       Impact factor: 4.246

3.  MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice.

Authors:  Weiguo Zou; Matthew B Greenblatt; Jae-Hyuck Shim; Shashi Kant; Bo Zhai; Sutada Lotinun; Nicholas Brady; Dorothy Zhang Hu; Steven P Gygi; Roland Baron; Roger J Davis; Dallas Jones; Laurie H Glimcher
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

4.  Short Stature Syndromes: Case Series from India.

Authors:  Inusha Panigrahi; Parminder Kaur; Chakshu Chaudhry; Mohd Shariq; Devika D Naorem; B C Gowtham; Anupriya Kaur; Devi Dayal
Journal:  J Pediatr Genet       Date:  2021-04-14

5.  Aarskog-Scott syndrome: a novel mutation in the FGD1 gene associated with severe craniofacial dysplasia.

Authors:  Christiane Völter; Ramón Martínez; Rudolf Hagen; Wolfram Kress
Journal:  Eur J Pediatr       Date:  2014-04-27       Impact factor: 3.183

6.  Activation of Rho GTPases in Smith-Lemli-Opitz syndrome: pathophysiological and clinical implications.

Authors:  Xiao-Sheng Jiang; Christopher A Wassif; Peter S Backlund; Li Song; Lynne A Holtzclaw; Zheng Li; Alfred L Yergey; Forbes D Porter
Journal:  Hum Mol Genet       Date:  2010-01-12       Impact factor: 6.150

7.  Clinical utility gene card for: Aarskog-Scott Syndrome (faciogenital dysplasia) - update 2015.

Authors:  Alfredo Orrico; Lucia Galli; Jill Clayton-Smith; Jean-Pierre Fryns
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

8.  Cerebrovascular disease associated with Aarskog-Scott syndrome.

Authors:  Michael L Diluna; Nduka M Amankulor; Michele H Johnson; Murat Gunel
Journal:  Neuroradiology       Date:  2007-02-10       Impact factor: 2.995

9.  Evolutionary genomics of human intellectual disability.

Authors:  Bernard Crespi; Kyle Summers; Steve Dorus
Journal:  Evol Appl       Date:  2009-09-07       Impact factor: 5.183

10.  Use of Targeted Exome Sequencing for Molecular Diagnosis of Skeletal Disorders.

Authors:  Daniel L Polla; Maria T O Cardoso; Mayara C B Silva; Isabela C C Cardoso; Cristina T N Medina; Rosenelle Araujo; Camila C Fernandes; Alessandra M M Reis; Rosangela V de Andrade; Rinaldo W Pereira; Robert Pogue
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.